Abstract
Variant Creutzfeldt–Jakob disease (vCJD) is a fatal degenerative brain disease, which probably passed into humans from cattle infected with bovine spongiform encephalopathy (BSE) or ‘mad cow disease’. Whatever its origins, the question arises of whether vCJD could be spread from person to person. Any such risk is very difficult to quantify, not least because the number of people already infected is unknown. This paper reflects on a study assessing the risk of transmission via instruments used in hospital surgery. The study underpinned a number of policy initiatives, including a £200 m programme to improve instrument decontamination. The methodology had to meet two major challenges. That of dealing with very large and multiple uncertainties was initially addressed using simple spreadsheet-based models to generate alternative scenarios. The complexity in the possible dynamics of vCJD within the population was then tackled. This paper outlines the models built and their use in eliciting expert judgement and informing risk management policy.
This is a preview of subscription content, log in via an institution to check access.
References
Will RG et al (1996). A new variant of CJD in the UK. Lancet 347: 921–925.
Bruce ME et al (1997). Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389: 498–501.
Hill AF et al (1997). The same prion strain causes vCJD and BSE. Nature 389: 448–450.
Cousens SN et al (1997). Predicting the CJD epidemic in humans. Nature 385: 197–198.
Ghani A et al (1998). Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. Proc R Soc Lond B 265: 2443–2452.
Will RG et al (1999). Deaths from vCJD. Lancet 353: 979.
Phillips et al (2000). Report into the Emergence and Identification of BSE and variant CJD and the Action Taken in Response to it up to 20th March 1996. Stationery Office: London.
Ironside JW et al (2000). Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet 355: 1693–1694.
Taylor DM (1999). Inactivation of prions by physical and chemical means. J Hosp Infection 43 (Suppl): S69–S76.
Taylor DM (2000). Inactivation of transmissible degenerative encephalopathy agents: A review. Vet J 159: 10–17.
Forrester JW (1961). Industrial Dynamics. MIT Press: Cambridge, MA.
Forrester JW (1968). Principles of Systems. MIT Press: Cambridge, MA.
Wolstenholme EW (1990). System Enquiry. Wiley: Chichester.
Dangerfield BC and Roberts CA (eds) (1999). Health and Health Care Dynamics. Special Issue. Syst Dyn Rev 15 (3).
Dangerfield BC et al (2001). Model-based scenarios for the epidemiology of HIV/AIDS: the consequences of highly active antiretroviral therapy. Syst Dyn Rev 17 (2): 119–150.
Townshend JRP and Turner HS (2000). Analysing the effectiveness of chlamydia screening. J Opl Res Soc 51: 812–824.
NHS Estates (2000). Decontamination review: report on a survey of current decontamination practices in healthcare premises in England. NHS Estates: Leeds.
NHS Estates (2001). A review of the decontamination of surgical instruments in the NHS in England. NHS Estates: Leeds.
CJD Incidents Panel (2001). Management of possible exposures to CJD through medical procedures: a consultation paper. Deptartment of Health: Leeds.
Bruce ME et al (2001). Detection of variant CJD infectivity in extraneural tissues. Lancet 358: 208–209.
Flechsig E et al (2001). Transmission of scrapie by steel-surface-bound prions. Mol Med 7: 680–685.
Bosque et al (2002). Prions in skeletal muscle. Proc Natl Acad Sci USA 99: 3812–3817.
Fichet G et al (2004). Novel methods for disinfection of prion-contaminated medical devices. Lancet 364: 521–526.
Huillard d’Aignaux JN et al (2001). Predictability of the UK vCJD Epidemic. Science 294: 1729–1731.
Ghani A et al (2002). Factors determining the pattern of the vCJD epidemic in Great Britain. Proc R Soc Lond B 270: 689–698.
Ghani A et al (2003). Updated projections of future vCJD deaths in the UK. BMC Infect Dis 3: 4.
Valleron AJ et al (2001). Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 294: 1726–1728.
Hilton D et al (2004). Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 202 (www.interscience.wiley.com).
Llewelyn CA et al (2004). Possible transmission of variant CJD by blood transfusion. Lancet 363: 417–421.
Peden AH et al (2004). Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 363: 527–529.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bennett, P., Hare, A. & Townshend, J. Assessing the risk of vCJD transmission via surgery: models for uncertainty and complexity. J Oper Res Soc 56, 202–213 (2005). https://doi.org/10.1057/palgrave.jors.2601899
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1057/palgrave.jors.2601899